# BAY38-9456 - Pivotal Trial for Diabetes Patient

> **NCT00678704** · PHASE3 · COMPLETED · sponsor: **Bayer** · enrollment: 790 (actual)

## Conditions studied

- Erectile Dysfunction
- Diabetes Mellitus

## Interventions

- **DRUG:** Levitra (Vardenafil, BAY38-9456)
- **DRUG:** Levitra (Vardenafil, BAY38-9456)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00678704
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** —
- **Final completion:** 2004-11
- **Target enrollment:** 790 (ACTUAL)
- **Last updated:** 2014-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00678704

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00678704, "BAY38-9456 - Pivotal Trial for Diabetes Patient". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00678704. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*